Literature DB >> 35067995

Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy.

C Colonna1, M Zussino1, N A Monzani2,3, A Ponziani1, R Cavalli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35067995     DOI: 10.1111/jdv.17963

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  1 in total

1.  Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study.

Authors:  Maddalena Napolitano; Gabriella Fabbrocini; Iria Neri; Luca Stingeni; Valeria Boccaletti; Vincenzo Piccolo; Giuseppe Fabrizio Amoruso; Giovanna Malara; Rocco De Pasquale; Eugenia Veronica Di Brizzi; Laura Diluvio; Luca Bianchi; Andrea Chiricozzi; Adriana Di Guida; Elisabetta Del Duca; Viviana Moschese; Vito Di Lernia; Federica Dragoni; Michaela Gruber; Katharina Hansel; Amelia Licari; Sara Manti; Salvatore Leonardi; Luca Mastorino; Michela Ortoncelli; Eugenio Provenzano; Antonino Palermo; Vincenzo Patella; Tiziana Peduto; Elena Pezzolo; Viviana Piras; Luca Potestio; Teresa Battista; Rosanna Satta; Stefania Termine; Paolo Palma; Paola Zangari; Cataldo Patruno
Journal:  Paediatr Drugs       Date:  2022-08-27       Impact factor: 3.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.